254 related articles for article (PubMed ID: 29449539)
21. The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer.
Mayr C; Helm K; Jakab M; Ritter M; Shrestha R; Makaju R; Wagner A; Pichler M; Beyreis M; Staettner S; Jaeger T; Klieser E; Kiesslich T; Neureiter D
Hum Pathol; 2018 Feb; 72():117-126. PubMed ID: 29133140
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of PCDHB9 promotes peritoneal metastasis and correlates with poor prognosis in patients with gastric cancer.
Mukai S; Oue N; Oshima T; Imai T; Sekino Y; Honma R; Sakamoto N; Sentani K; Kuniyasu H; Egi H; Tanabe K; Yoshida K; Ohdan H; Yasui W
J Pathol; 2017 Sep; 243(1):100-110. PubMed ID: 28671736
[TBL] [Abstract][Full Text] [Related]
23. The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.
Pan MR; Hsu MC; Luo CW; Chen LT; Shan YS; Hung WC
Oncotarget; 2016 Sep; 7(38):61136-61151. PubMed ID: 27531902
[TBL] [Abstract][Full Text] [Related]
24. Human telomerase reverse transcriptase (hTERT) synergistic with Sp1 upregulate Gli1 expression and increase gastric cancer invasion and metastasis.
Wu L; Wang S; Tang B; Tang L; Lei Y; Liu Y; Yang M; Yang G; Zhang D; Liu E
J Mol Histol; 2021 Dec; 52(6):1165-1175. PubMed ID: 34601664
[TBL] [Abstract][Full Text] [Related]
25. G9a Promotes Invasion and Metastasis of Non-Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway.
Sun T; Zhang K; Pangeni RP; Wu J; Li W; Du Y; Guo Y; Chaurasiya S; Arvanitis L; Raz DJ
Mol Cancer Res; 2021 Mar; 19(3):429-440. PubMed ID: 33298547
[TBL] [Abstract][Full Text] [Related]
26. A post-translational modification switch controls coactivator function of histone methyltransferases G9a and GLP.
Poulard C; Bittencourt D; Wu DY; Hu Y; Gerke DS; Stallcup MR
EMBO Rep; 2017 Aug; 18(8):1442-1459. PubMed ID: 28615290
[TBL] [Abstract][Full Text] [Related]
27. Extracellular vesicle derived miR-544 downregulates expression of tumor suppressor promyelocytic leukemia zinc finger resulting in increased peritoneal metastasis in gastric cancer.
Kong W; Liu X; Yin G; Zheng S; Zhu A; Yu P; Shan Y; Ying R; Zhang J
Aging (Albany NY); 2020 Nov; 12(23):24009-24022. PubMed ID: 33221764
[TBL] [Abstract][Full Text] [Related]
28. Abnormal overexpression of G9a in melanoma cells promotes cancer progression via upregulation of the Notch1 signaling pathway.
Dang NN; Jiao J; Meng X; An Y; Han C; Huang S
Aging (Albany NY); 2020 Feb; 12(3):2393-2407. PubMed ID: 32015216
[TBL] [Abstract][Full Text] [Related]
29. MTA2 promotes gastric cancer cells invasion and is transcriptionally regulated by Sp1.
Zhou C; Ji J; Cai Q; Shi M; Chen X; Yu Y; Liu B; Zhu Z; Zhang J
Mol Cancer; 2013 Sep; 12(1):102. PubMed ID: 24010737
[TBL] [Abstract][Full Text] [Related]
30. Scinderin promotes the invasion and metastasis of gastric cancer cells and predicts the outcome of patients.
Liu JJ; Liu JY; Chen J; Wu YX; Yan P; Ji CD; Wang YX; Xiang DF; Zhang X; Zhang P; Cui YH; Wang JM; Bian XW; Qian F
Cancer Lett; 2016 Jun; 376(1):110-7. PubMed ID: 27033455
[TBL] [Abstract][Full Text] [Related]
31. Novel Function of Lysine Methyltransferase G9a in the Regulation of Sox2 Protein Stability.
Lee JY; Lee SH; Heo SH; Kim KS; Kim C; Kim DK; Ko JJ; Park KS
PLoS One; 2015; 10(10):e0141118. PubMed ID: 26492085
[TBL] [Abstract][Full Text] [Related]
32. SETDB1 promotes gastric carcinogenesis and metastasis via upregulation of CCND1 and MMP9 expression.
Shang W; Wang Y; Liang X; Li T; Shao W; Liu F; Cui X; Wang Y; Lv L; Chai L; Qu L; Zheng L; Jia J
J Pathol; 2021 Feb; 253(2):148-159. PubMed ID: 33044755
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of G9a triggers DNA damage response and inhibits colorectal cancer cells proliferation.
Zhang J; He P; Xi Y; Geng M; Chen Y; Ding J
Oncotarget; 2015 Feb; 6(5):2917-27. PubMed ID: 25595900
[TBL] [Abstract][Full Text] [Related]
34. G9a orchestrates PCL3 and KDM7A to promote histone H3K27 methylation.
Pan MR; Hsu MC; Chen LT; Hung WC
Sci Rep; 2015 Dec; 5():18709. PubMed ID: 26688070
[TBL] [Abstract][Full Text] [Related]
35. G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma.
Liu S; Ye D; Guo W; Yu W; He Y; Hu J; Wang Y; Zhang L; Liao Y; Song H; Zhong S; Xu D; Yin H; Sun B; Wang X; Liu J; Wu Y; Zhou BP; Zhang Z; Deng J
Oncotarget; 2015 Mar; 6(9):6887-901. PubMed ID: 25749385
[TBL] [Abstract][Full Text] [Related]
36. microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling.
Gao P; Wang S; Jing F; Zhan J; Wang Y
Cancer Biomark; 2017; 19(1):11-20. PubMed ID: 28269747
[TBL] [Abstract][Full Text] [Related]
37. G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis.
Casciello F; Al-Ejeh F; Kelly G; Brennan DJ; Ngiow SF; Young A; Stoll T; Windloch K; Hill MM; Smyth MJ; Gannon F; Lee JS
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):7077-7082. PubMed ID: 28630300
[TBL] [Abstract][Full Text] [Related]
38. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
[TBL] [Abstract][Full Text] [Related]
39. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M
PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131
[TBL] [Abstract][Full Text] [Related]
40. SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma.
Zhu Y; Zhu MX; Zhang XD; Xu XE; Wu ZY; Liao LD; Li LY; Xie YM; Wu JY; Zou HY; Xie JJ; Li EM; Xu LY
Hum Pathol; 2016 Jun; 52():153-63. PubMed ID: 26980013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
